BJU Int. 2005 Apr;95(6):838-41.
Sacral magnetic stimulation in non-inflammatory chronic pelvic pain syndrome.
Leippold T, Strebel RT, Huwyler M, John HA, Hauri D, Schmid DM.
Department of Urology, University Hospital Zurich, Switzerland.
Abstract
OBJECTIVES: To prospectively evaluate sacral magnetic high-frequency stimulation as a treatment option for patients with non-inflammatory chronic pelvic pain syndrome (CPPS, category IIIB).
PATIENTS AND METHODS: Fourteen men with CPPS IIIB were treated with high-frequency sacral magnetic stimulation, with 10 treatment sessions once a week for 30 min at a frequency of 50 Hz. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) and quality-of-life index were determined before and after treatment.
RESULTS: All patients tolerated the stimulation well and 12 of 14 reported agreeable sensations during stimulation. There were no complications; only one patient did not complete the treatment course. The mean (range) total NIH-CPSI score did not change with treatment, at 27 (18-38) before and 27 (4-40) after treatment. Moreover, there was no sustained effect on the mean scores for pain, micturition complaints or quality of life.
CONCLUSIONS: High-frequency sacral magnetic stimulation in patients with CPPS IIIB only reduces pain during stimulation, with no sustained relief of symptoms. Therefore, intermittent sacral magnetic stimulation cannot be recommended as a treatment option for CPPS IIIB.
| Urol Nefrol (Mosk). 1996 Sep-Oct;(5):10-4. |
Magnetic-laser therapy in inflammatory and posttraumatic lesions of the urinary system.
[Article in Russian]
Loran OB, Kaprin AD, Gazimagomedov GA.
The authors discuss disputable problem of renal and ureteral tissue after trauma or inflammation. These cause irreversible morphological changes in the tissue. Poor results of the standard therapy urged the authors to try magnetic-laser therapy in urological clinic. The technique has been developed on experimental animal models. The resultant morphological characteristics of ureteral wall and parenchyma support the validity of magnetic-laser therapy in urological practice.
| Vopr Kurortol Fizioter Lech Fiz Kult. 1996 Sep-Oct;(5):22-5. |
The effect of a low-frequency magnetic field on the clinico-immunological indices of patients with chronic inflammatory diseases of the organs of the female genital system.
[Article in Russian]
Markina LP, Iarustovskaia OV, Alisultanova LS, Derevnina NA, Gontar’ EV.
Low-frequency magnetic field generated by the vaginal inductor used in 120 females with chronic genital inflammation promoted a decrease in leukocytosis, elevation of total population of T-lymphocytes, inhibition of high proliferative activity in PHA test. However, marked immunocorrection was not reached.
Clin Exp Obstet Gynecol. 1995;22(4):350-4.
Analgesic properties of electromagnetic field therapy in patients with chronic pelvic pain.
Varcaccio-Garofalo G, Carriero C, Loizzo MR, Amoruso S, Loizzi P.
Institute of Obstetrics and Gynecology II Clinic, University of Bari, Italy.
Abstract
AIM: Demonstration of analgesic effects of electromagnetic field treatment in cases of chronic refractory pelvic pain.
STUDY DESIGN: Prospective non-controlled trial, 64 women complaining about pelvic pain of at least 6 months duration, resistant to standard therapies, submitted to electromagnetic field applications on both iliac regions by Thelf Systems apparatus by two applications daily lasting 2 hours each for 20-40 days. Control visit after 3 months.
RESULTS: Complete subsidence of pain in 39 cases (61%), in 15 patients (23%) relief during treatment, then mild endopelvic tension after a 3-month control; in 10 cases (16%) symptoms reduced only during application hours, unchanged at follow-up. Outcome of treatment appears to be independent of pre-existent psychosocial variables.
CONCLUSION: Magnetic therapy shows a real analgesic effect on pelvic pain, and seems to contribute to resolution of complex interactions between somatic nociceptive stimuli and psychosocial implications affecting pain perception in these patients.